Single Ascending Dose Study of PRX002 in Healthy Subjects

This study has been completed.
Sponsor:
Collaborator:
Hoffmann-La Roche
Information provided by (Responsible Party):
Prothena Biosciences Limited
ClinicalTrials.gov Identifier:
NCT02095171
First received: March 14, 2014
Last updated: February 9, 2015
Last verified: February 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: No date given
  Primary Completion Date: December 2014 (Final data collection date for primary outcome measure)